Today we can announce that Neuronostics is partnering with Stratus, a leading provider of cloud-based, ambulatory EEG services.

This collaboration will support the integration of our BioEP technology into clinical practice across extensive networks, ultimately helping to support more timely and informed decisions for people undergoing investigation for suspected epilepsy.

Through the partnership BioEP will become embedded within Stratus’ EEG platform, creating a streamlined pathway for clinicians and facilitating access through Stratus’ national networks. With connections to more than 600 hospitals and a significant annual patient referral base, this collaboration offers an important opportunity to real-world impact at scale.

We also welcome Charlie Alvarez, CEO of Stratus, to the Neuronostics Board of Directors. His perspective and experience will be invaluable as we look to grow our footprint in the US healthcare landscape.

“This partnership represents a pivotal moment in our mission to transform neurological care,” said Professor John Terry, Co-Founder and Managing Director of Neuronostics. “By combining our breakthrough digital biomarker with Stratus’ unparalleled clinical network and expertise, we’re creating a pathway to help millions of patients receive faster, more accurate diagnoses. The potential to reduce the anxiety and uncertainty that patients and families face during the diagnostic process drives our work every day.”